Evaluation of the sample-to-result, random access NeuMoDx platform for viral load testing of Cytomegalovirus and Epstein Barr virus in clinical specimens

•The NeuMoDx 96 and 288 are fully-automated molecular sample-in-result-out systems.•The NeuMoDx CMV and EBV assays are suitable for detection and quantification in clinical specimens.•The CMV assay of NeuMoDx is more sensitive compared to the LDT.•The Abbott m2000 EBV assay seems to under-quantify compared to the NeuMoDx assay.